Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases [Phase 4]

View source ↗

Summary

Phase 4 trial update on prevention of recurrence of herpes simplex in patients with autoimmune rheumatic diseases. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex | Phase 4 | Status: NOT_YET_RECRUITING